Antipsychotic drugs: Comparison in animal models of efficacy, neurotransmitter regulation, and neuroprotection

Jeffrey A. Lieberman, Frank P. Bymaster, Herbert Y. Meltzer, Ariel Y. Deutch, Gary E. Duncan, Christine E. Marx, June R. Aprille, Donard S. Dwyer, Xin Min Li, Sahebarao P. Mahadik, Ronald S. Duman, Joseph H. Porter, Josephine S. Modica-Napolitano, Samuel S. Newton, John G. Csernansky

Research output: Contribution to journalReview article

163 Citations (Scopus)

Abstract

Various lines of evidence indicate the presence of progressive pathophysiological processes occurring within the brains of patients with schizophrenia. By modulating chemical neurotransmission, antipsychotic drugs may influence a variety of functions regulating neuronal resilience and viability and have the potential for neuroprotection. This article reviews the current literature describing preclinical and clinical studies that evaluate the efficacy of antipsychotic drugs, their mechanism of action and the potential of first- and second-generation antipsychotic drugs to exert effects on cellular processes that may be neuroprotective in schizophrenia. The evidence to date suggests that although all antipsychotic drugs have the ability to reduce psychotic symptoms via D2 receptor antagonism, some antipsychotics may differ in other pharmacological properties and their capacities to mitigate and possibly reverse cellular processes that may underlie the pathophysiology of schizophrenia.

Original languageEnglish (US)
Pages (from-to)358-403
Number of pages46
JournalPharmacological Reviews
Volume60
Issue number3
DOIs
StatePublished - Sep 1 2008

Fingerprint

Antipsychotic Agents
Neurotransmitter Agents
Animal Models
Schizophrenia
Aptitude
Synaptic Transmission
Action Potentials
Neuroprotection
Pharmacology
Brain

ASJC Scopus subject areas

  • Molecular Medicine
  • Pharmacology

Cite this

Lieberman, Jeffrey A. ; Bymaster, Frank P. ; Meltzer, Herbert Y. ; Deutch, Ariel Y. ; Duncan, Gary E. ; Marx, Christine E. ; Aprille, June R. ; Dwyer, Donard S. ; Li, Xin Min ; Mahadik, Sahebarao P. ; Duman, Ronald S. ; Porter, Joseph H. ; Modica-Napolitano, Josephine S. ; Newton, Samuel S. ; Csernansky, John G. / Antipsychotic drugs : Comparison in animal models of efficacy, neurotransmitter regulation, and neuroprotection. In: Pharmacological Reviews. 2008 ; Vol. 60, No. 3. pp. 358-403.
@article{1fdcb724bb914fb585e534fa31aa6bdf,
title = "Antipsychotic drugs: Comparison in animal models of efficacy, neurotransmitter regulation, and neuroprotection",
abstract = "Various lines of evidence indicate the presence of progressive pathophysiological processes occurring within the brains of patients with schizophrenia. By modulating chemical neurotransmission, antipsychotic drugs may influence a variety of functions regulating neuronal resilience and viability and have the potential for neuroprotection. This article reviews the current literature describing preclinical and clinical studies that evaluate the efficacy of antipsychotic drugs, their mechanism of action and the potential of first- and second-generation antipsychotic drugs to exert effects on cellular processes that may be neuroprotective in schizophrenia. The evidence to date suggests that although all antipsychotic drugs have the ability to reduce psychotic symptoms via D2 receptor antagonism, some antipsychotics may differ in other pharmacological properties and their capacities to mitigate and possibly reverse cellular processes that may underlie the pathophysiology of schizophrenia.",
author = "Lieberman, {Jeffrey A.} and Bymaster, {Frank P.} and Meltzer, {Herbert Y.} and Deutch, {Ariel Y.} and Duncan, {Gary E.} and Marx, {Christine E.} and Aprille, {June R.} and Dwyer, {Donard S.} and Li, {Xin Min} and Mahadik, {Sahebarao P.} and Duman, {Ronald S.} and Porter, {Joseph H.} and Modica-Napolitano, {Josephine S.} and Newton, {Samuel S.} and Csernansky, {John G.}",
year = "2008",
month = "9",
day = "1",
doi = "10.1124/pr.107.00107",
language = "English (US)",
volume = "60",
pages = "358--403",
journal = "Pharmacological Reviews",
issn = "0031-6997",
publisher = "American Society for Pharmacology and Experimental Therapeutics",
number = "3",

}

Lieberman, JA, Bymaster, FP, Meltzer, HY, Deutch, AY, Duncan, GE, Marx, CE, Aprille, JR, Dwyer, DS, Li, XM, Mahadik, SP, Duman, RS, Porter, JH, Modica-Napolitano, JS, Newton, SS & Csernansky, JG 2008, 'Antipsychotic drugs: Comparison in animal models of efficacy, neurotransmitter regulation, and neuroprotection', Pharmacological Reviews, vol. 60, no. 3, pp. 358-403. https://doi.org/10.1124/pr.107.00107

Antipsychotic drugs : Comparison in animal models of efficacy, neurotransmitter regulation, and neuroprotection. / Lieberman, Jeffrey A.; Bymaster, Frank P.; Meltzer, Herbert Y.; Deutch, Ariel Y.; Duncan, Gary E.; Marx, Christine E.; Aprille, June R.; Dwyer, Donard S.; Li, Xin Min; Mahadik, Sahebarao P.; Duman, Ronald S.; Porter, Joseph H.; Modica-Napolitano, Josephine S.; Newton, Samuel S.; Csernansky, John G.

In: Pharmacological Reviews, Vol. 60, No. 3, 01.09.2008, p. 358-403.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Antipsychotic drugs

T2 - Comparison in animal models of efficacy, neurotransmitter regulation, and neuroprotection

AU - Lieberman, Jeffrey A.

AU - Bymaster, Frank P.

AU - Meltzer, Herbert Y.

AU - Deutch, Ariel Y.

AU - Duncan, Gary E.

AU - Marx, Christine E.

AU - Aprille, June R.

AU - Dwyer, Donard S.

AU - Li, Xin Min

AU - Mahadik, Sahebarao P.

AU - Duman, Ronald S.

AU - Porter, Joseph H.

AU - Modica-Napolitano, Josephine S.

AU - Newton, Samuel S.

AU - Csernansky, John G.

PY - 2008/9/1

Y1 - 2008/9/1

N2 - Various lines of evidence indicate the presence of progressive pathophysiological processes occurring within the brains of patients with schizophrenia. By modulating chemical neurotransmission, antipsychotic drugs may influence a variety of functions regulating neuronal resilience and viability and have the potential for neuroprotection. This article reviews the current literature describing preclinical and clinical studies that evaluate the efficacy of antipsychotic drugs, their mechanism of action and the potential of first- and second-generation antipsychotic drugs to exert effects on cellular processes that may be neuroprotective in schizophrenia. The evidence to date suggests that although all antipsychotic drugs have the ability to reduce psychotic symptoms via D2 receptor antagonism, some antipsychotics may differ in other pharmacological properties and their capacities to mitigate and possibly reverse cellular processes that may underlie the pathophysiology of schizophrenia.

AB - Various lines of evidence indicate the presence of progressive pathophysiological processes occurring within the brains of patients with schizophrenia. By modulating chemical neurotransmission, antipsychotic drugs may influence a variety of functions regulating neuronal resilience and viability and have the potential for neuroprotection. This article reviews the current literature describing preclinical and clinical studies that evaluate the efficacy of antipsychotic drugs, their mechanism of action and the potential of first- and second-generation antipsychotic drugs to exert effects on cellular processes that may be neuroprotective in schizophrenia. The evidence to date suggests that although all antipsychotic drugs have the ability to reduce psychotic symptoms via D2 receptor antagonism, some antipsychotics may differ in other pharmacological properties and their capacities to mitigate and possibly reverse cellular processes that may underlie the pathophysiology of schizophrenia.

UR - http://www.scopus.com/inward/record.url?scp=54049141721&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=54049141721&partnerID=8YFLogxK

U2 - 10.1124/pr.107.00107

DO - 10.1124/pr.107.00107

M3 - Review article

C2 - 18922967

AN - SCOPUS:54049141721

VL - 60

SP - 358

EP - 403

JO - Pharmacological Reviews

JF - Pharmacological Reviews

SN - 0031-6997

IS - 3

ER -